Rheographic normalization in prediabetic subjects treated with pyridinolcarbamate
Furitano, G.; Paterna, S.; Di Pasquale, P.
Minerva Medica 69(24): 1655-1659
1978
ISSN/ISBN: 0026-4806 PMID: 662168 Document Number: 133454
Document emailed within 1 workday
Related Documents
Notarbartolo, A.; Rini, G.B.; Di Fede, G. 1973: Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate Bollettino Della Societa Italiana di Cardiologia 18(4): 379-383Lenti, G.; Pagano, G.; Trovati, M.; Pisu, E. 1977: Plasma insulin detection in the study of prediabetic subjects Panminerva Medica 19(2): 87-94
Hossain, I.A.; Faruque, M.O.; Akter, S.; Bhuiyan, F.R.; Rahman, M.K.; Ali, L. 2016: Elevated levels of serum uric acid and insulin resistance are associated with nonalcoholic fatty liver disease among prediabetic subjects Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 37(2): 101-111
Seoane, M.R.; De Contardi, N.W. 1971: Action of pyridinolcarbamate on platelet aggregation and adhesive platelet count in normal subjects Prensa Medica Argentina 58(2): 92-99
Boismare, F.; Hacpille, L.; Belliard, J.P. 1975: Rheographic study of the effects of dihydroergotamine on the encephalic and peripheral hemodynamics in healthy subjects Therapie 30(1): 149-156
Kragballe, K.; Ternowitz, S.; Herlin, T. 1985: Normalization of monocyte chemotaxis precedes clinical resolution of psoriasis treated with benoxaprofen Acta Dermato-Venereologica 65(4): 319-323
Ricci, C.; Minetto, E.; Cascio, G.; De Stefano, A.; Basso, M.; Borelli, P.; Bozzone, D.; Delia, D.; Baldassi, R. 1984: Normalization of electrophoretic mobility of lymphocytes in patients with primary immunoglobulin deficiency treated with intravenous immunoglobulins Acta Medica Hungarica 41(4): 297-302
Klotz, H.P.; Romani, J.D. 1972: Value of skin biopsy in prediabetic patients Annales de Medecine Interne 123(1): 79-83
Khodorchuk, N.I. 1971: Detection of prediabetic states in obese children Pediatriia 50(3): 74-75
Kallal, Z. 1971: Aggravation of prediabetic states by corticosteroid therapy La Tunisie Medicale 4: 239-241
Sidorenko, G.I.; Borisova, G.S.; Sidorenko, E.R.; Polonetskii, L.Z.; Gelis, L.G. 1983: Psychophysiological aspect of the therapeutic use of pyridinolcarbamate Kardiologiia 23(3): 66-71
Pecora, P.; Arata, L.; Iacovoni, P. 1970: The behavior of sideremia in subjects treated with salicylate Bollettino della Societa Italiana di Biologia Sperimentale 46(2): 58-61
Eisenbarth, G.S. 2004: Prediction of type 1 diabetes: the natural history of the prediabetic period Advances in Experimental Medicine and Biology 552: 268-290
De Luca, M.; Ciampo, E.; Rossi, A. 1971: Study of the seminal fluid in subjects treated with methotrexate Giornale Italiano di Dermatolotia. Minerva Dermatologica 46(6): 247-249
Birbari, A.E. 1992: How frequent is sexual dysfunction in hypertensive subjects and how is it treated? Le Journal Medical Libanais. Lebanese Medical Journal 40(3): 174
Messina, L.; Palmieri, S.; Bonnì, G.; D'Alessandro, N.; Rausa, L.; Raineri, A. 1981: Serial echocardiographic evaluation of subjects treated with adriamycin Bollettino Della Societa Italiana di Cardiologia 26(12): 2231-2237
Benyamin, A.Fachruddin.; Bayu, D.; Minhajat, R. 2016: Association Between PAI-1 Activity Levels and t-PA Antigen with Glycemic Status in Prediabetic Population Acta Medica Indonesiana 48(3): 200-206
Perrin, A.; Loire, R.; Petiot, M. 1972: Study of pyridinolcarbamate in the prevention of experimental atheroma in rabbits Lyon Medical 227(3): 247-253
Bellotti, L.; Frigo, G. 1983: Quantitative simultaneous determination with HPLC of clofibrate and pyridinolcarbamate Bollettino Chimico Farmaceutico 122(3): 143-148
Mantovani, P.; Impicciatore, M. 1970: Some pharmacological activities of 2,6-bis-(hydroxymethyl)pyridin-bis-(N-methylcarbamate) (Pyridinolcarbamate) Il Farmaco; Edizione Scientifica 25(12): 912-919